Company profile
Better Testing, Better Treatment - Diaceutics
Diaceutics have worked on every Precision Medicine brought to market in partnership with leading pharmaceuticals. #bettertestingbettertreatment.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
SH01 | Transaction MzUyNTk4NTg5OGFkaXF6a2N4
Published 09 Jun 2026 07:09
Last confirmation statement made up date
SH01 | Transaction MzUxNTM5NzY4MGFkaXF6a2N4
Published 10 Apr 2026 15:06
Last accounts made up date
SH01 | Transaction MzQ0Mjg0MDk4M2FkaXF6a2N4
Published 12 Nov 2024 05:06
CERT21 | Transaction MzQ0MTg3NTQxOGFkaXF6a2N4 | Paper/PDF filed
Published 09 Nov 2024 07:42
OC138 | Transaction MzQ0MTg3NDgzNGFkaXF6a2N4 | Paper/PDF filed
Published 09 Nov 2024 07:08
SH19 | Transaction MzQ0MTg3Njc1N2FkaXF6a2N4 | Paper/PDF filed
Published 09 Nov 2024 07:07
AP01 | Transaction MzQzODk0Nzc1MGFkaXF6a2N4
Published 09 Oct 2024 04:32
TM01 | Transaction MzQzODk0NjkxNGFkaXF6a2N4
Published 09 Oct 2024 04:21
TM01 | Transaction MzQzODk0NjkxM2FkaXF6a2N4
Published 09 Oct 2024 04:21
Company registered at Companies House
1 Nov 2024 to 31 Oct 2029
**The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT)** is a partnership of Life and Health Science (LHS) companies and Academia, aligned to the strategies of both the Departments of Health and Economy of the NI devolved government to enhance health and wealth creation for NI citizens. Currently, NI has a significant presence in ...
1 Aug 2019 to 31 Jul 2021
To deliver and embed pharmacoeconomic modelling analysis tools and capabilities in the company that demonstrate overall value of better diagnostic testing delivers via improved utilisation of precision medicine therapies.
